Population pharmacokinetics and pharmacodynamics study of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation

Trial Profile

Population pharmacokinetics and pharmacodynamics study of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation

Completed
Phase of Trial: Phase IV

Latest Information Update: 19 Oct 2017

At a glance

  • Drugs Mycophenolate mofetil (Primary) ; Tacrolimus
  • Indications Graft-versus-host disease
  • Focus Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 19 Oct 2017 New trial record
    • 09 Oct 2017 Results published in the Bone Marrow Transplantation
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top